MECHANISMS OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
MECHANISMS OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
批准号:
3254115
负责人:
STEPHEN L KAATTARI
金额:
$11.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1996-04-30
关键词:
B lymphocyte aflatoxins anamnestic reaction antibody formation antibody specificity antiidiotype antibody antiserum autologous transplantation benzanthracenes benzopyrenes cellular pathology chemical carcinogen cyclophosphamide disease /disorder model electrofocusing enzyme linked immunosorbent assay immune tolerance /unresponsiveness immunity immunoglobulin genes immunoglobulin idiotypes immunologic memory immunotoxicity laboratory mouse mitogens molecular pathology monoclonal antibody nitrophenol passive immunization radiation dosage tissue /cell culture trout /salmon
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability of aflatoxin B1 (AFB1) and other carcinogens to induce
immunosuppression in animals has been well documented. However, analysis
of the molecular and cellular mechanisms involved have yet to be addressed.
The Shasta strain of rainbow trout, aside from being an excellent animal
model for the induction of hepatocellular carinomas by AFB1, also
demonstrates the induction of immune dysfunctions to this agent. These
dysfunctions are related to an inability to develop immunological memory
and may be the result of deficits in immune regulation either by
non-lymphoid or lymphoid cells. Conversely, they may be due to direct
genotoxic damage to the B lymphocyte. Thus, the goals of this study are to
1) perform molecular and cellular analyses of the immune responses
generated in AFB1-exposed fish to determine the origin of this immune
dysfunction and 2) to examine other genotoxic carcinogens/immunotoxicants
for similar forms of immunosuppression.
Shifts in fine specificity of antibodies generated in AFB1 -exposed animals
must be due to the altered expression of antibody by B cell populations.
This may occur either through changes in the regulation of memory
development or by direct effects on B lymphocytes. Characterization of
antibodies by fine specificity, spectrotypic, and idiotypic analyses will
permit the "fingerprinting" of these antibody populations, which in turn
will be used to determine if the apparent shift in antibody repertoires are
due to random or non-random processes. These techniques will also provide
the necessary tools that will be required for future genetic analyses.
The cellular origin of this memory dysfunction will be addressed by the use
of precursor frequency analysis, mitogenic assays coupled with cellular
partitioning techniques and adoptive cell transfers. Studies devoted to
the study of the cellular mechanisms involved during embryonic and in vitro
AFB1 exposure will require the development of autologous and syngeneic cell
transfer systems. The use of syngeneic strains of trout will also be of
benefit to immunological research in general and also provide the means by
which the long-term propagation and study of tumor lines may be realized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A real-time antibody-based field assay to predict containment bioavailability in
-
批准号:8230061
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2011
-
负责人:STEPHEN L KAATTARI
-
依托单位:
A real-time antibody-based field assay to predict containment bioavailability in
-
批准号:8402397
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2011
-
负责人:STEPHEN L KAATTARI
-
依托单位:
A real-time antibody-based field assay to predict containment bioavailability in
-
批准号:8576456
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2011
-
负责人:STEPHEN L KAATTARI
-
依托单位:
MECHANISM OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
-
批准号:2154663
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1991
-
负责人:STEPHEN L KAATTARI
-
依托单位:
MECHANISM OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
-
批准号:2154664
-
项目类别:
-
资助金额:$12.38万
-
财政年份:1991
-
负责人:STEPHEN L KAATTARI
-
依托单位:
MECHANISM OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
-
批准号:3254117
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1991
-
负责人:STEPHEN L KAATTARI
-
依托单位:
MECHANISMS OF CARCINOGEN-INDUCED IMMUNE DYSFUNCTION
-
批准号:3254114
-
项目类别:
-
资助金额:$11.14万
-
财政年份:1991
-
负责人:STEPHEN L KAATTARI
-
依托单位:
海外基金